The "Europe Liquid Biopsy Market: Focus on End User and Country - Analysis and Forecast, 2024-2033" report has been added to ...

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

Liquid Biopsy MarketThe global liquid biopsy market is poised for substantial expansion, with an estimated revenue of USD 1,538.3 million in 2023. The market is projected to grow at an impressive ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Discover how PEARL, a cfDNA-based method, enhances early preeclampsia detection, offering safer, non-invasive prenatal ...

The latest buzz in the cancer diagnosis and treatment arena is a revolutionary technology called liquid biopsy. Unlike tissue biopsies, which involve extracting a sample from a suspected tumour ...

Liquid biopsy is emerging as a less invasive method for cancer detection and monitoring. High adoption rates are seen in oncology and prenatal diagnostics. Liquid Biopsy Tube Market growth was valued ...

Q4 2024 . Management View. CEO Chris Smith highlighted strong financial performance, with Q4 revenue reaching $172 million, ...

As serum biomarkers are not optimal for early diagnosis, liquid biopsy has emerged as a promising tool for diagnosis, prognostication, and patients’ stratification for personalized therapy in various ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...